Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment.
作者信息
Ortolani Federica, Piccinno Elvira, Grasso Valeria, Papadia Francesco, Panzeca Rossana, Cortese Claudio, Felappi Barbara, Tummolo Albina, Vendemiale Marcella, Barbetti Fabrizio
机构信息
Department of Metabolic Diseases, Clinical Genetics and Diabetology, Giovanni XXIII Children's Hospital, Via Amendola 207, 70126, Bari, Italy.
Department of Experimental Medicine and Surgery, University of Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.
出版信息
Acta Diabetol. 2016 Jun;53(3):499-501. doi: 10.1007/s00592-015-0793-1. Epub 2015 Aug 4.
Abstract
摘要
相似文献
1
Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment.与显性胰岛素基因突变相关的糖尿病：24个月动态血糖监测辅助胰岛素泵治疗的结果
Acta Diabetol. 2016 Jun;53(3):499-501. doi: 10.1007/s00592-015-0793-1. Epub 2015 Aug 4.
2
Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.1型糖尿病患者实时连续血糖监测的健康经济学分析
Diabet Med. 2015 May;32(5):618-26. doi: 10.1111/dme.12661. Epub 2015 Jan 6.
3
A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.传感器增强型胰岛素泵治疗和自动胰岛素暂停与 1 型糖尿病低血糖无知患者的标准泵治疗的成本效益分析。
Value Health. 2014 Jul;17(5):561-9. doi: 10.1016/j.jval.2014.05.008. Epub 2014 Jul 15.
4
Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.传感器增强型胰岛素泵治疗和自动胰岛素暂停与标准胰岛素泵治疗对 1 型糖尿病患者低血糖的影响：一项随机临床试验。
JAMA. 2013 Sep 25;310(12):1240-7. doi: 10.1001/jama.2013.277818.
5
Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.1型糖尿病中，与单纯持续皮下胰岛素输注相比，传感器增强泵治疗的长期健康经济效益：英国视角
J Med Econ. 2016;19(3):236-42. doi: 10.3111/13696998.2015.1113979. Epub 2015 Nov 19.
6
STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.STAR 3 随机对照临床试验比较了传感器增强型胰岛素泵治疗与多次皮下注射在 1 型糖尿病治疗中的效果：研究设计、方法和入组患者的基线特征。
Diabetes Technol Ther. 2010 Apr;12(4):249-55. doi: 10.1089/dia.2009.0145.
7
Use of sensor-augmented insulin pump in patient with diabetes and cystic fibrosis: evidence for improvement in metabolic control.在糖尿病合并囊性纤维化患者中使用传感器增强型胰岛素泵：代谢控制改善的证据。
Diabetes Technol Ther. 2008 Feb;10(1):46-9. doi: 10.1089/dia.2007.0238.
8
Management of insulin pump therapy in children with type 1 diabetes.1型糖尿病儿童的胰岛素泵治疗管理
Arch Dis Child Educ Pract Ed. 2014 Dec;99(6):214-20. doi: 10.1136/archdischild-2013-304501. Epub 2014 Aug 14.
9
Living with sensor-augmented pump therapy in type 1 diabetes: adolescents' and parents' search for harmony.1 型糖尿病患者使用传感器增强型胰岛素泵治疗的生活体验：青少年和家长寻求和谐。
Can J Diabetes. 2014 Aug;38(4):256-62. doi: 10.1016/j.jcjd.2014.02.002. Epub 2014 Jul 9.
10
Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment of Hypo-Prone Type 1 Diabetes In Hungary.
Value Health. 2014 Nov;17(7):A344. doi: 10.1016/j.jval.2014.08.695. Epub 2014 Oct 26.
引用本文的文献
1
Synthetic studies of the mutant proinsulin syndrome demonstrate correlation between folding efficiency and age of diabetes onset.突变胰岛素原综合征的合成研究表明折叠效率与糖尿病发病年龄之间存在相关性。
Int J Pept Res Ther. 2025 Jan;31(1). doi: 10.1007/s10989-024-10665-z. Epub 2024 Nov 20.
2
Neonatal diabetes mellitus around the world: Update 2024.全球新生儿糖尿病：2024年最新情况
J Diabetes Investig. 2024 Dec;15(12):1711-1724. doi: 10.1111/jdi.14312. Epub 2024 Sep 30.
3
Insulin Delivery Technology for Treatment of Infants with Neonatal Diabetes Mellitus: A Systematic Review.用于治疗新生儿糖尿病患儿的胰岛素给药技术：一项系统评价
Diabetes Ther. 2024 Nov;15(11):2293-2308. doi: 10.1007/s13300-024-01653-z. Epub 2024 Sep 18.
4
Use of a long-term continuous glucose monitor for predicting sulfonylurea dose in patients with neonatal diabetes mellitus: a case series.使用长期连续血糖监测仪预测新生儿糖尿病患者的磺脲类药物剂量：病例系列
Clin Pediatr Endocrinol. 2024;33(3):131-138. doi: 10.1297/cpe.2023-0062. Epub 2025 Mar 8.
5
The Changing Landscape of Neonatal Diabetes Mellitus in Italy Between 2003 and 2022.意大利 2003 年至 2022 年期间新生儿糖尿病发病情况的变化。
J Clin Endocrinol Metab. 2024 Aug 13;109(9):2349-2357. doi: 10.1210/clinem/dgae095.
6
Long-term sensor-augmented pump therapy for neonatal diabetes mellitus: a case series.新生儿糖尿病的长期传感器增强泵治疗：病例系列
Clin Pediatr Endocrinol. 2022;31(3):178-184. doi: 10.1297/cpe.2022-0005. Epub 2022 May 1.
7
Peptide Model of the Mutant Proinsulin Syndrome. I. Design and Clinical Correlation.突变胰岛素原综合征的肽模型。I. 设计与临床相关性。
Front Endocrinol (Lausanne). 2022 Mar 1;13:821069. doi: 10.3389/fendo.2022.821069. eCollection 2022.
8
Peptide Model of the Mutant Proinsulin Syndrome. II. Nascent Structure and Biological Implications.突变胰岛素原综合征的肽模型。二、新生结构与生物学意义。
Front Endocrinol (Lausanne). 2022 Mar 1;13:821091. doi: 10.3389/fendo.2022.821091. eCollection 2022.
9
Diabetes-Associated Mutations in Proinsulin Provide a "Molecular Rheostat" of Nascent Foldability.与糖尿病相关的胰岛素原突变提供了新生折叠性的“分子变阻器”。
Curr Diab Rep. 2022 Feb;22(2):85-94. doi: 10.1007/s11892-022-01447-2. Epub 2022 Feb 4.
10
Novel Pathogenic De Novo INS p.T97P Variant Presenting With Severe Neonatal DKA.新型致病性从头 INS p.T97P 变异导致严重新生儿糖尿病酮症酸中毒。
Endocrinology. 2022 Feb 1;163(2). doi: 10.1210/endocr/bqab246.
本文引用的文献
1
Insulin therapy for pre-hyperglycemic beta-cell endoplasmic reticulum crowding.针对高血糖前期β细胞内质网拥挤的胰岛素治疗。
PLoS One. 2013;8(2):e54351. doi: 10.1371/journal.pone.0054351. Epub 2013 Feb 7.
2
Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births.意大利新生儿/婴儿期发病的糖尿病发病率最低为每 9 万活产 1 例。
Acta Diabetol. 2012 Oct;49(5):405-8. doi: 10.1007/s00592-011-0331-8. Epub 2011 Sep 28.
3
Insulin gene mutations as cause of diabetes in children negative for five type 1 diabetes autoantibodies.胰岛素基因突变导致五例 1 型糖尿病自身抗体阴性患儿发生糖尿病。
Diabetes Care. 2009 Jan;32(1):123-5. doi: 10.2337/dc08-0783. Epub 2008 Oct 7.
4
Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus.人类胰岛素基因中的七个突变与永久性新生儿/婴儿期糖尿病相关。
J Clin Invest. 2008 Jun;118(6):2148-56. doi: 10.1172/JCI33777.
5
Insulin gene mutations as a cause of permanent neonatal diabetes.胰岛素基因突变是永久性新生儿糖尿病的一个病因。
Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15040-4. doi: 10.1073/pnas.0707291104. Epub 2007 Sep 12.
Zotero 插件